ICA-069673
≥98%
- Product Code: 100908
CAS:
582323-16-8
Molecular Weight: | 269.63 g./mol | Molecular Formula: | C₁₁H₆ClF₂N₃O |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8℃ |
Product Description:
ICA-069673 is primarily investigated for its potential therapeutic applications in the treatment of autoimmune diseases and inflammatory conditions. It functions as a selective inhibitor of TYK2 (tyrosine kinase 2), a key enzyme involved in signaling pathways of cytokines such as IL-12, IL-23, and type I interferons. By targeting TYK2, it modulates immune responses, making it a promising candidate for managing diseases like psoriasis, lupus, and inflammatory bowel disease. Its selectivity reduces the risk of broad immunosuppression, potentially offering a safer profile compared to non-selective kinase inhibitors. Research continues to explore its efficacy and safety in clinical settings.
Product Specification:
Test | Specification |
---|---|
Appearance | White To Off-White Solid |
Purity (%) | 97.5-100 |
Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿7,000.00 |
+
-
|
0.010 | 10-20 days | ฿11,560.00 |
+
-
|
0.050 | 10-20 days | ฿36,800.00 |
+
-
|
0.100 | 10-20 days | ฿57,600.00 |
+
-
|
ICA-069673
ICA-069673 is primarily investigated for its potential therapeutic applications in the treatment of autoimmune diseases and inflammatory conditions. It functions as a selective inhibitor of TYK2 (tyrosine kinase 2), a key enzyme involved in signaling pathways of cytokines such as IL-12, IL-23, and type I interferons. By targeting TYK2, it modulates immune responses, making it a promising candidate for managing diseases like psoriasis, lupus, and inflammatory bowel disease. Its selectivity reduces the risk of broad immunosuppression, potentially offering a safer profile compared to non-selective kinase inhibitors. Research continues to explore its efficacy and safety in clinical settings.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :